New Trends in Gaucher Disease: A Model for Rare Lysosomal Disorders
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 8308
Special Issue Editors
2. Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
Interests: Gaucher disease; lysosomal disorders; GBA-related Parkinson disease
Special Issues, Collections and Topics in MDPI journals
2. Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
Interests: Gaucher disease; pediatric hematology; pediatric thrombosis and hemostasis; platelet disorders
Special Issues, Collections and Topics in MDPI journals
Interests: lysosomal storage diseases; Gaucher disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are excited to invite you to be part of our new Special Issue of the International Journal of Molecular Sciences entitled: "Advances in Gaucher Disease: A Model for Rare Lysosomal Disorders". Gaucher disease is truly a remarkable model for rare diseases. It was among the first genetic disorders to demonstrate genotype–phenotype relationships using PCR-based methodology, and the first lysosomal storage disorder (LSD) to benefit from the orphan drug law three decades ago, and to have different therapeutic options.
Although rare world-wide (1:50,000–100,000), it has a high prevenance among Ashkenazi Jews, and most of the patients with the so called "adult type" or type 1 live a normal lifespan, thereby allowing long term assessments as well as larger cohorts of patients compared to lethal disorders at a young age. There are also diverse animal models from different mice through drosophila fruit flies to zebra fish and human derived iPSCs, providing endless research opportunities. Gaucher disease was the very first lysosomal storage disease to have a safe and effective intravenous enzyme replacement therapy, to get market approval for oral substrate reduction therapy, and in addition, there are several additional treatment modalities such as pharmacological chaperones different gene therapy approaches.
Still, there are many unmet needs and unresolved challenges, including the lack of treatment for the neuronopathic forms, the high cost of therapies leaving many untreated patients in poor countries, and the associations with common diseases such as various malignancies and neurodegenerative disorders, particularly Parkinson’s disease. With regard to the latter, we may be able in the near future to leverage the knowledge from Gaucher disease to the development of innovative therapies for these most common disorders, making the research of Gaucher disease all the more important.
We are looking forward to receiving your contributions, and to what we believe might be an excellent up-to-date issue on all aspects of Gaucher disease, from basic science to clinical observations and therapies.
Prof. Dr. Ari Zimran
Prof. Dr. Shoshana Revel-Vilk
Prof. Dr. Edward I. Ginns
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
